Drug Trial Radar · NCT04784533
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Last checked: Nov 19, 2026Latest source record: Oct 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
317
Actual
Start
Feb 26, 2021
Primary completion
May 16, 2023
Study completion May 16, 2023
Sponsor
- Lead sponsor
- Concert PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Mar 5, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the regrowth of hair with CTP-543 and subsequent durability of that regrowth following dose reduction in adult patients with moderate to severe alopecia areata.
Conditions
- Alopecia Areata
Interventions
CTP-543Drug
Oral dosing
PlaceboDrug
Oral dosing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A, Period 2: Percentage of Participants Achieving Loss of Regrowth Maintenance (LOM) Criteria Defined by Severity of Alopecia Tool (SALT) Score > 20 Following Dose ReductionTime frame: From Week 24 to Week 48
- Part A, Period 2: Percentage of Participants Achieving LOM Criteria Defined by SALT Score > 20 Following Drug DiscontinuationTime frame: From Week 24 to Week 48
- Part B: Percentage of Participants by Dose Group Who Achieved Restoration of Regrowth (ROR) at Week 24Time frame: Week 24 of re-treatment
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
Total Skin and Beauty Dermatology Center, PC
Birmingham, Alabama
Center for Dermatology and Plastic Surgery/CCT Research
Scottsdale, Arizona
Kern Research, Inc.
Bakersfield, California
Hope Clinical Research
Canoga Park, California
California Dermatology & Clinical Research Institute
Encinitas, California
University of California, Irvine
Irvine, California
Quest Dermatology Research
Northridge, California
Kaiser Permanente
Oakland, California
Palmtree Clinical Research, Inc.
Palm Springs, California
Kaiser Permanente
San Francisco, California
Colorado Center for Dermatology and Skin Surgery
Centennial, Colorado
Colorado Medical Research Center, Inc.
Denver, Colorado
Yale University Church Street Research Unit
New Haven, Connecticut
Skin Care Research, LLC
Boca Raton, Florida
Skin Care Research, LLC
Hollywood, Florida
DeNova Research
Chicago, Illinois
The Indiana Clinical Trials Center, PC
Plainfield, Indiana
DS Research
Louisville, Kentucky
Michigan Center for Research Company, LLC
Clarkston, Michigan
University of Minnesota Department of Dermatology
Minneapolis, Minnesota
Minnesota Clinical Study Center
New Brighton, Minnesota
Skin Specialists, PC
Omaha, Nebraska
Skin Laser and Surgery Specialists of New Jersey
Hackensack, New Jersey
Darst Dermatology
Charlotte, North Carolina
Dermatology Specialists of Charlotte
Charlotte, North Carolina
North Carolina Dermatology Associates, PLLC
Raleigh, North Carolina
Bexley Dermatology Research
Bexley, Ohio
Remington Davis
Columbus, Ohio
Vital Prospects Clinical Research Institute, PC
Tulsa, Oklahoma
Northwest Dermatology
Portland, Oregon
Dermatology Associates of Plymouth Meeting
Plymouth Meeting, Pennsylvania
PEAK Research, LLC
Upper Saint Clair, Pennsylvania
Rhode Island Hospital
Providence, Rhode Island
Clinical Research Center of the Carolinas
Charleston, South Carolina
Dermatology Treatment and Research Center, PA
Dallas, Texas
Austin Institute for Clinical Research
Houston, Texas
Austin Institute for Clinical Research, Inc.
Pflugerville, Texas
Springville Dermatology/CCT Research
Springville, Utah
West End Dermatology Associates
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.